On January 2, 2024, Bioleaders Corporation closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,340 KRW | +2.86% | -11.36% | +9.86% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,870 KRW | +2.23% | -0.15% | 197M | ||
2,340 KRW | +2.86% | -11.36% | 62.78M | ||
1st Jan change | Capi. | |
---|---|---|
+9.86% | 62.78M | |
+29.55% | 682B | |
+30.35% | 586B | |
-3.75% | 364B | |
+17.47% | 327B | |
+3.29% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.37% | 165B |
- Stock Market
- Equities
- A142760 Stock
- News MOA Life Plus Co. Ltd.
- Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.